Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPRY: TX-12-002-HR in Secondary Amenorrhea
NCT02019589Phase 3Terminated
- Sponsor
- TherapeuticsMD
- Start
- Jan 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of progesterone in secondary amenorrhea (3 arms), sponsored by TherapeuticsMD. Primary endpoint: Proportion of subjects with complete secretory activity on endometrial biopsy. Started Jan 2014; status: terminated.
02
Drugs
progesterone
03
Conditions
secondary amenorrhea
Beyond the preview
Go deeper on NCT02019589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019589.